Fosfluconazole

福司氟康唑

Report date: 2022/09/08 17:54:38
NME

Base Information

Drug NameFosfluconazole
Drug Alias NameFosfluconazol福司康唑Fosfluconazolum磷氟康唑Prodif +[7] 
ClassificationSmall molecules > Heterocyclic drugs > Antifungals
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsCryptococcosisCandidiasisMycoses
Global Approved IndicationsCryptococcosisCandidiasisMycoses
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2003/10/16
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaIND
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncShaanxi Synthetic Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCryptococcosisCandidiasisMycoses
Inactive IndicationsN/A

Other Information

ATC CodeD01AC15J02AC01
Related LinksWikipediaKEGG